Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis

Objective. To determine the prevalence of antineutrophil cytoplasmic autoantibodies (ANCA) in sera of patients with tuberculosis compared with healthy control subjects and a group of patients with atopic asthma. Methods. The presence of ANCA was examined in patients with tuberculosis, and in asthmat...

Full description

Saved in:
Bibliographic Details
Published inRheumatology (Oxford, England) Vol. 42; no. 2; pp. 223 - 229
Main Authors Flores‐Suárez, L. F., Cabiedes, J., Villa, A. R., van der Woude, F. J., Alcocer‐Varela, J.
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.02.2003
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective. To determine the prevalence of antineutrophil cytoplasmic autoantibodies (ANCA) in sera of patients with tuberculosis compared with healthy control subjects and a group of patients with atopic asthma. Methods. The presence of ANCA was examined in patients with tuberculosis, and in asthmatic patients and healthy subjects as control groups, by means of indirect immunofluorescence (IIF) and enzyme‐linked immunosorbent assay (ELISA) to detect anti‐proteinase 3 (PR3‐ANCA) and antimyeloperoxidase (MPO‐ANCA) antibodies. Results. ANCA were present in 20 (44.4%) of 45 tuberculosis patients by IIF (16 c‐ANCA, four p‐ANCA) and in 18 (40%) patients by ELISA (15 PR3‐ANCA, three MPO‐ANCA). High odds ratios for ANCA positivity were observed for tuberculosis patients when compared with both control groups. ANCA results were not related to the category of tuberculosis, stage of disease, presence of concomitant diseases or pharmacotherapy. Conclusions. As many clinical similarities between tuberculosis and Wegener's granulomatosis exist, we propose that a positive ANCA test in patients living in countries with a high prevalence of tuberculosis must be carefully interpreted as indicative of systemic vasculitis, especially when no signs of extrapulmonary involvement occur.
Bibliography:istex:29BB324C37FC28469B0BFBF283A15955D16B2394
local:420223
ark:/67375/HXZ-3NFHCGMW-J
PII:1460-2172
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1462-0324
1462-0332
DOI:10.1093/rheumatology/keg066